Sanofi Consumer Healthcare India Ltd. benchmarking: Perfomance to industry peers

Financial

	Sanofi Cons. Health	Sanofi India	Rubicon Research
Operational Metrics
Financials
5 yr Average ROE	72.87 %	52.02 %	5.76 %
5yr average Equity Multiplier	1.82	4.62	2.29
5yr Average Asset Turnover Ratio	1.48	0.47	0.66
5yr Avg Net Profit Margin	27.34 %	24.38 %	1.04 %
Price to Book	43.68	12.8	19.8
P/E	56.13	26.66	79.71
5yr Avg Cash Conversion Cycle	-83.69 Days	4.83 Days	-23.11 Days
Inventory Days	47.09 Days	66.8 Days	96.45 Days
Days Receivable	10.93 Days	31.98 Days	88.85 Days
Days Payable	135.97 Days	63.37 Days	228.02 Days
5yr Average Interest Coverage Ratio	32.14	906.11	2.59
5yr Avg ROCE	99.14 %	27.19 %	12.78 %
5yr Avg Operating Profit Margin	38.38 %	24.71 %	11.87 %
5 yr average Debt to Equity	0.0	0.0	0.74
5yr CAGR Net Profit	1.88 %	31.63 %	34.36 %
5yr Average Return on Assets	40.56 %	11.5 %	1.79 %
Shareholdings
Promoter Holding	71.27 %	60.4 %	n/a
Share Pledged by Promoters	0.0	0.0	n/a
Change in Promoter Holding (3 Yrs)	10.87 %	0.0	n/a
Change in Mutual Fund Holding (3 Yrs)	0.28 %	0.97 %	n/a

	Sanofi Cons. Health	Sanofi India	Rubicon Research
Product Wise Break-Up	Product Wise Break-Up Consumer Healthcare Product 100.0 Pharmaceuticals 0 Export benefits, royalty etc. 0 Income from research services 0 Sale of pharmaceutical goods 0	Product Wise Break-Up Income from research services 0 Pharmaceutical 100.0 Consumer Healthcare Product 0 Sale of pharmaceutical goods 0 Export benefits, royalty etc. 0	Product Wise Break-Up Income from research services 0.08 Pharmaceuticals 0 Consumer Healthcare Product 0 Sale of pharmaceutical goods 98.15 Export benefits, royalty etc. 1.77
Location Wise Break-Up	Location Wise Break-Up India 90.53 Outside India 9.47 Singapore 0 USA 0	Location Wise Break-Up Singapore 20.29 USA 0 India 79.71 Outside India 0	Location Wise Break-Up Singapore 0 USA 99.5 India 0.32 Outside India 0 Others 0.18